Marvell Technology (MRVL) Tops Q4 EPS by 1c, Offers Guidance
Get Alerts MRVL Hot Sheet
Price: $237.04 -5.57%
Revenue Growth %: +34.8%
Financial Fact:
General and administrative: 28.9M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Revenue Growth %: +34.8%
Financial Fact:
General and administrative: 28.9M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Marvell Technology (NASDAQ: MRVL) reported Q4 EPS of $0.80, $0.01 better than the analyst estimate of $0.79. Revenue for the quarter came in at $2.22 billion versus the consensus estimate of $2.21 billion.
GUIDANCE:
Marvell Technology sees Q1 2027 EPS of $0.74-$0.84, versus the consensus of $0.74. Marvell Technology sees Q1 2027 revenue of $2.4 billion, versus the consensus of $2.28 billion.
For earnings history and earnings-related data on Marvell Technology (MRVL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Starts Marvell (MRVL) at Outperform
- Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
- Nuvectis Pharma (NVCT) files $200M mixed shelf
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share